Literature DB >> 17634308

Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, Version 1.5, on clinical laboratory operations.

Jeffrey J Germer1, Jordan L Bendel, Craig A Dolenc, Sarah R Nelson, Amanda L Masters, Tara M Gerads, Jayawant N Mandrekar, P Shawn Mitchell, Joseph D C Yao.   

Abstract

The COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5 (CAP/CA), and the COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, were compared. CAP/CA reduced and consolidated labor while modestly increasing assay throughput without increased failure rates or direct costs, regardless of batch size and assay format.

Entities:  

Mesh：

Year:  2007        PMID： 17634308      PMCID： PMC2045285          DOI： 10.1128/JCM.00656-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation).

Authors:  Annemarie Berger; Lina Scherzed; Martin Stürmer; Wolfgang Preiser; Hans W Doerr; Holger F Rabenau
Journal:  J Clin Virol       Date:  2002-12       Impact factor: 3.168

2.  Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.

Authors:  Annemarie Berger; Lina Scherzed; Martin Stürmer; Wolfgang Preiser; Hans Wilhelm Doerr; Holger Felix Rabenau
Journal:  J Clin Virol       Date:  2005-05       Impact factor: 3.168

3.  Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.

Authors:  T R O'Brien; W A Blattner; D Waters; E Eyster; M W Hilgartner; A R Cohen; N Luban; A Hatzakis; L M Aledort; P S Rosenberg; W J Miley; B L Kroner; J J Goedert
Journal:  JAMA       Date:  1996-07-10       Impact factor: 56.272

4.  Evaluation of an automated sample preparation protocol for quantitative detection of hepatitis C virus RNA.

Authors:  Evelyn Stelzl; Andrea Kormann-Klement; Josef Haas; Elisabeth Daghofer; Brigitte I Santner; Egon Marth; Harald H Kessler
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.

Authors:  R W Coombs; S L Welles; C Hooper; P S Reichelderfer; R T D'Aquila; A J Japour; V A Johnson; D R Kuritzkes; D D Richman; S Kwok; J Todd; J B Jackson; V DeGruttola; C S Crumpacker; J Kahn
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

Review 6.  Automation of laboratory testing for infectious diseases using the polymerase chain reaction-- our past, our present, our future.

Authors:  D Jungkind
Journal:  J Clin Virol       Date:  2001-01       Impact factor: 3.168

7.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.